baber/WOPTO huggingface dataset:
Patent JP-2001523257-A (JP)
Title: カルシトニン受容体結合ペプチド
IPC: A61K51/08
Filed: 1998-05-01
Abstract: (57)【要約】
本発明は、放射性金属キレート化剤に共有結合するカルシトニン受容体結合試薬に関する。本発明は、適当な同位元素で放射性標識できるカルシトニン受容体結合ペプチド誘導体およびカルシトニンのアナログとして具体化され、放射性診断剤または放射性治療剤として用いられる。また、哺乳動物体内の診断的および治療的なかかる試薬を製造する、放射性標識する、および使用するための方法およびキットが提供される。
Patent JP-2001526802-A (JP)
Title: 容器を開封して空にする装置及び方法、並びに該装置の用途
IPC: G03C5/26
Filed: 1998-05-22
Abstract: (57)【要約】
密封膜から成る部材で密封された差し口を有する容器（17）を開封して空にする装置(1,22)が、差し口を受け入れて容器を支持するようになった受け口(３)と、密封膜を突き刺し、これに切れ目を入れるようになった切断手段（23）と、注ぎ口の実質的に内腔全体を開ける切れ目を密封膜に入れるために受け口を切断手段に対して移動させる第１の駆動手段（10）とを有している。本発明は更に、容器を開封して空にする方法を提供する。
Patent NZ-208971-A (NZ)
Title: Marine propulsion;propellor longitudinal duct in hull above transverse control vane
Inventor: CZERNIAK MARIAN KAZIMIERZ EDWA
IPC: B63H5/16
Filed: 1984-07-20
Abstract: PCT No. PCT/GB84/00258 Sec. 371 Date Mar. 12, 1985 Sec. 102(e) Date Mar. 12, 1985 PCT Filed Jul. 7, 1983 PCT Pub. No. WO85/00572 PCT Pub. Date Feb. 14, 1985.A self-propelled waterborne vessel has a generally flat hull undersurface aft of the bow region from which extend side walls (10) and keels (11, 12) defining longitudinally extending channels (8, 9) of which the length approximates to one-third of the length of the vessel. Ducted portions of the channels contain propellers (21) aft of which the ducted portion cross-section is selectively variable by transversely pivoted vanes (18). The attitude of the vessel is controllable by the vanes (18) and by further vanes (36) at the stern. Steering is effected by a propulsive steering unit (25) comprising ducts containing propellers (32) and transversely pivoted vanes (34). Additional ducted propellers (46) can be provided aft and may be retractable into the hull.
Patent NZ-212577-A (NZ)
Title: Topical anti-inflammatory compositions containing naphthalene derivatives
Inventor: THOMSON M J
IPC: A61K31/12
Filed: 1985-06-27
Abstract: Pharmaceutical compositions which comprise a compound of the formula (I):wherein X is a chlorine or bromine atom or a methoxyl, methylthio or alkyl group of 1-4 carbon atoms; Y is a -CHR<sub>1</sub>-CH<sub>2</sub>- or -CR,=CH- group where R, is a hydrogen atom or a methyl group and A is a CHOH or CO group, and a topically effective pharmaceutically acceptable carrier, possess local topical anti-inflammatory activity, and possess systemic anti-inflammatory activity when administered topically.
Patent NZ-217433-A (NZ)
Title: Colour panel standards sorting system
Inventor: ALMAN D H
IPC: B07C5/342
Filed: 1986-09-02
Abstract: A process for forming paint panel color standards, in which a multiplicity of panels are painted and marked with a man/machine readable ID number, comprises:(1) electronically determining the ID number of each panel, measuring each panel color coordinate values, and feeding this information to a computer which establishes criteria for various panel quality standards;(2) sorting the panels by electronically determining panelID number and feeding the number to the computer which signals a robot to place the panel with a group of panels having the same quality standard.
Patent NZ-220640-A (NZ)
Title: Fusing gathered throat portion of plastics bag with heated needles
Inventor: LIPES A
IPC: B65D33/16
Filed: 1987-06-10
Abstract: A plastic bag for retaining a content therein has a gathered throat portion (11) adjacent an end opening (13) thereof, the gathered throat portion (11) being formed by randomly disposed wall portions of the plastic material fused together by two or more rows of adjacent spaced apart fused zones (27) of plastic material disposed about a plurality of needle holes (25). Apparatus for forming the bag comprises at least one set of opposed gathering jaw plates (12, 12') for gathering, in a random fashion, a circumferential portion of the plastic bag adjacent the end opening (13) thereof to form a gathered throat portion (11). Two pressing plates (14) are disposed on a respective side of the gathered throat portion (11) and are each provided with two or more spaced apart rows of needle receiving bores (16) disposed adjacent one another in differing planes (21,21',21''). A needle support block (17) of heat conductive material has needles (18) secured thereto for conducting heat from the block (17). The block (17) is connected for movement to and away from one of the pressing plates (14) once the pressing plates (14) have moved to a pressing position so that the needles (18) will enter the bores (16) of both pressing plates (14) to puncture a press portion of the gathered throat portion (11) of the bag to fuse plastic material adjacent randomly disposed wall portions of the plastic material in the areas (26) of the penetrating needles (18) and in adjacent spaced apart planes (21,21',21'').
Patent NZ-232713-A (NZ)
Title: Derivatives of 1-hydroxy-1,2,4-triazoles and fungicidal compositions
Inventor: BAUS ULF
IPC: C07D521/00
Filed: 1990-02-27
Abstract: Compounds of the general formula   <IMAGE> I  where X is CH2 or O, Y is hydrogen, alkyl, alkoxy, halogen, aryl or aryloxy and n is from 1 to 5, and their salts and complexes, and fungicides containing these compounds.
Patent NZ-233850-A (NZ)
Title: Fire protection glass unit
Inventor: NOLTE HANS-HENNING
IPC: E06B3/58
Filed: 1990-05-29
Abstract: A fire barrier used with a glass pane and a metal frame has a circumferential receiving groove. The edge of the glass pane ends in front of the metal frame. Connected to the edge of the glass pane is a compensation adaptor which has two adaptor strips bonded to the edge region of the glass pane and engages into the receiving groove with projections of the adaptor strips. A strip-shaped non-metallic spacer is arranged between the projections. 
<IMAGE>
Patent NZ-236684-A (NZ)
Title: Process and apparatus for the preparation of peroxycarboxylic acid bleaching and sanitising composition at the point of use, and solutions using it
Inventor: LOKKESMOE KEITH D
IPC: A61L2/18
Filed: 1991-01-04
Abstract: We have found a new and useful process to generate peroxy acid sanitizing and bleaching compositions at the point-of-use, the process comprising introducing hydrogen peroxide and a carboxylic acid into a reactor at about 0.1 to 10 moles of hydrogen peroxide per mole of acid, and contacting the hydrogen peroxide and carboxylic acid in the presence of a sulfonic acid resin and in the substantial abssence of active metal ions which forms an aqueous peroxy acid composition at a concentration from about up to 20 wt %. Using this process, warewashing, laundry sanitizing and bleach, and hard surface sanitizing compositions can be produced.
Patent NZ-241063-A (NZ)
Title: N-mercaptoalkylamide derivatives; preparatory processes and pharmaceutical compositions
Inventor: NEUSTADT BERNARD R
IPC: A61K31/44
Filed: 1991-12-19
Abstract: Novel N-(mercaptoalkyl)amides of the formula  <IMAGE>  wherein R1 is lower alkyl, cyclolower alkyl, aryl or heteroaryl; R2 is (COR3)-aryl, heteroaryl, substituted (COR3)-aryl or substituted heteroaryl, wherein the substituents are 1-3 substituents selected from the group consisting of carboxy, alkoxycarbonyl, lower alkyl, hydroxy, halo, lower alkoxy, cyclolower alkyl, cyano, trifluoromethyl, phenyl, phenoxy and phenylthio; R3 is -OR4 or -NR4R5; R4 and R5 are independently selected from the group consisting of hydrogen, lower alkyl, hydroxy lower alkyl, lower alkoxy lower alkyl and aryl lower alkyl, or R4 and R5 together with the nitrogen to which they are attached form a 5-, 6- or 7-membered ring; Q is hydrogen or R6CO-; R6 is hydrogen, lower alkyl or aryl; and m is 1 or 2; and the pharmaceutically acceptable salts thereof useful in the treatment of cardiovascular disorders, nephrotoxicity and pain conditions and combinations of N-(mercaptoalkyl)amides and atrial natriuretic factors or angiotensin converting enzyme inhibitors useful for treating cardiovascular disorders are disclosed.
Patent NZ-245031-A (NZ)
Title: Casein hydrolysate and its enzymatic production.
Inventor: NIELSEN PER MUNK
IPC: A23J3/34
Filed: 1992-11-05
Abstract: PCT No. PCT/DK92/00326 Sec. 371 Date Apr. 13, 1994 Sec. 102(e) Date Apr. 13, 1994 PCT Filed Sep. 9, 1992 PCT Pub. No. WO93/08702 PCT Pub. Date May 13, 1993.The new casein hydrolyzate does not contain any unhydrolyzed casein and is characterized by a defined molecular weight distribution. The method is characterized by being performed by means of three defined proteolytic enzymes and a non-pH star method. The casein hydrolyzate exhibits an optimal balance between DH, free amino acids, bitterness and yield.
Patent NZ-260863-A (NZ)
Title: Uhf antenna, support and coupler mountable on vehicle windscreen
Inventor: BACNIK JAMES A
IPC: H01Q1/12
Filed: 1994-06-27
Abstract: A window mounted antenna system having a foot or exterior support member attached to an antenna radiator or whip and typically mounted on the outside of a window or dielectric member comprised of a plastic decorative housing, a conductive foot portion which acts as the coupling capacitor and is inserted into the cover and conductively connected to the radiating member or whip, and a fastener for attaching the whip to the foot or base portion. The conductive foot includes attachment fingers insertable into the housing and retained in place upon insertion therein, and one or more flanges for receiving a fastener passed through the end of the antenna. A coupling assembly disposed on the other side of the window includes a formed or stamped conductive element which incorporates the various conductive components which make up the coupling assembly. The conductive components are overmolded with a nonconductive support material to produce an integrated structure incorporating the various components of the coupling assembly. <IMAGE>
Patent NZ-292786-A (NZ)
Title: Process of treating sewage comprising addition of an alkaline additive and pasteurisation; apparatus
Inventor: CHRISTY PAUL G
IPC: C02F11/14
Filed: 1995-09-06
Abstract: A process and apparatus for treating sewage sludge having the steps of providing sludge at a desired rate, mixing the sludge with at least one alkaline additive at a proportionate rate to the sludge to raise the pH of the mixture to at least a desired level, providing a pasteurization chamber having a means to heat the contents of the chamber, continuously delivering the sludge and alkaline additive mixture to the inlet opening of the pasteurization chamber, heating the pasteurization chamber to maintain a minimum temperature of the sludge and alkaline additive mixture in the pasteurization chamber, continuously conveying the sludge and alkaline additive mixture without any substantial agitation of the mixture for a desired duration through the pasteurization chamber such that the thixotropic mixture does not become watery, and continuously discharging the sludge and alkaline additive mixture from the discharge opening of the pasteurization chamber, whereby harmful pathogens are destroyed in the sludge.
Patent NZ-334922-A (NZ)
Title: Tool for reducing column strength and for welding overlapping strap portions
Inventor: FIGIEL JANUSZ
IPC: B25B25/00
Filed: 1999-03-30
Abstract: A strapping tool 100, for welding overlapping strap portions 2, 3, comprises: a sealing gripper 30 movable toward a first support member 12 to engage and retain a tensioned strap 1 disposed between the sealing gripper and the first support member; a vibratable welding pad 40 movable toward a second support member 42 to weld overlapping strap portions 2, 3 disposed between the welding pad 40 and the second support member; a vertex 120 between the sealing gripper 30 and the welding pad 40, the overlapping strap portions 2, 3 disposed over the vertex. The column strength of a portion of the overlapping strap portions 2, 3 is reduced before the strap portions disposed between pad 40 and support member 42 are welded together.  The column strength may be reduced by bending the overlapping portions over the vertex 120 or by forming a gap between an upper strap portion 3 and a lower strap portion 2 between gripper 30 and pad 40.
Patent NZ-334994-A (NZ)
Title: Reel of sheet of plastic material with indentation so that it can be folded to protect edges of rolled products such as rolled sheet
Inventor: HUNT RAYMOND JOHN
IPC: B65D85/66
Filed: 1997-09-08
Abstract: An edge protector is disclosed for the edges of roll shaped articles, e.g. pallets, reeled steel and paper products and is made from an elongated sheet (10) of plastics material, the sheet having an indentation (11) extending longitudinally along a major surface of the sheet and extending only partially into the thickness of the sheet. The indentation (11) divides the sheet into webs (12, 13) which are folded into and L-shape. The edge protector is initially in the form of a reel but after un-reeling  it is able to be bent into an angled form long enough for it to be placed on a reeled product.
Patent NZ-335949-A (NZ)
Title: Blending fuel wherein two fuels are passed through a single meter and through a sensor signalling the octane level of the mixture
Inventor: NANAJI SEIFOLLA S
IPC: G05D11/13
Filed: 1999-05-25
Abstract: The fuel dispensing apparatus consists of:  first and second fuel sources 100, 200 of different octane levels;  a blending system (typically with blend selectors 353) including respective flow control valves 306, 308 to control the first and second fuel flow rates;  first and second octane level sensors 102, 202 to sense respective octane levels;  site controller 400 for receiving octane signals and controlling blending by determining if a predetermined blend can be created based on the measured octane levels and to permit fuel dispensing only if such a blend can be achieved;  and a fuel dispenser nozzle 10.
Patent NZ-336493-A (NZ)
Title: A method of oocyte enucleation and production of reconstituted embryos
Inventor: PEURA TEIJA
IPC: C12N5/16
Filed: 1997-12-22
Abstract: An oocyte having a polar body, metaphase plate and cytoplasm is subjected to a compound such as a phytohemagglutinin (PHA) aggregate solution, which causes attachment of the polar body to the oocyte, and then enucleated by separating the polar body and a portion of cytoplasm containing the metaphase plate from remaining cytoplasm.  The techniques are useful in nuclear transplantation for the production of nuclear transfer (particularly bovine) embryos and multiple genetically similar offspring.
Patent NZ-506053-A (NZ)
Title: N-tuple or ram based neural network classification system which boosts cells having positive column vector cell values and corresponding n-tuples
Inventor: JORGENSEN THOMAS MARTINI
IPC: G06N3/04
Filed: 1999-02-02
Abstract: The invention relates to a system and a method of training a computer classification system which can be defined by a network comprising a number of n-tuples or Look Up Tables (LUTs), with each n-tuple or LUT comprising a number of rows corresponding to at least a subset of possible classes and comprising columns being addressed by signals or elements of sampled training input data examples, each column being defined by a vector having cells with values, the method comprising determining the column vector cell values based on one or more training sets of training input data examples for different classes so that at least part of the cells comprise or point to information based on the number of times the corresponding cell address is sampled from one or more sets of training input examples, and determining weight cell values corresponding to one or more column vector cells being addressed or sampled by the training examples to thereby allow weighting of one or more column vector cells of positive value during a classification process, said weight cell values being determined based on the information of at least part of the determined column vector cell values and by use of at least part of the training set(s) of input examples. A second aspect of the invention is a system and a method for determining - in a computer classification system - weight cell values corresponding to one or more column vector cells being addressed by the training examples, wherein the determination is based on the information of at least part of the determined vector cell values, said determination allowing weighting of column vector cells having a positive value or a non-positive value. Finally the invention provides a method and a system for classifying input data examples into a plurality of classes using the computer classification systems.
Patent NZ-509939-A (NZ)
Title: 1H-imidazopyridine derivatives useful as TNF or IL-1 inhibitors
Inventor: SAKAGUCHI JUN
IPC: A61P37/02
Filed: 1999-08-12
Abstract: A 1H-imidazopyridine derivative or a salt thereof has the formula (I) or (II) wherein R1 is hydrogen, hydroxyl or optionally substituted alkyl, cycloalkyl, styryl, or aryl; R2 is hydrogen, alkyl, halogen, hydroxyl or an optionally substituted amino, a cyclic amino, or a phenoxy; Ring A is an optionally substituted carbocyclic or a heterocyclic ring; R3 is an optionally substituted saturated nitrogen-containing heterocyclic; m is an integer from 0 to 3; R4 is hydrogen, alkyl, benzyl, triphenylmethyl or optionally substituted alkanoyl, alkoxycarbonyl, benzyloxycarbonyl, an optionally substituted thiocarbamoyl, alkanesulphonyl, optionally substituted benzenesulphonyl or amidine; Y is methylene, oxygen, sulphur, nitrogen, NH, or a single bond and n is 0 to 2 provided that, when R3 is an unsubstituted piperidino, at least one of R1 and R2 is not hydrogen atom. A pharmaceutical composition thereof is useful for treating diseases in which a cytokine is mediated.
Patent NZ-512410-A (NZ)
Title: Controlled release liquid filled gelatin capsules comprising barrier, expandable and superpermeable layers and an orifice
Inventor: DONG LIANG C
IPC: A61K9/52
Filed: 1999-12-10
Abstract: A dosage form comprising a gelatin capsule formed with a composite wall and containing a liquid, active agent formulation where the wall comprises a barrier layer formed over the external surface of the gelatin capsule, and expandable layer formed over the barrier layer and a semipermeable layer formed over the expandable layer is described. The dosage forms and methods provide for the conversion of standard gelatin, liquid formulation capsules into controlled, release dosage forms that permit the controlled release of the active agent into the environment of use over time. The gelatin capsule (12) is surrounded by a barrier layer (18), except in the area in which the exit orifice (24) is formed.  Barrier layer (18) is itself surrounded by an expandable layer (20), which is itself surrounded by an external semipermeable layer (22).  An exit orifice (24) is formed through external layer (22), expandable layer (20) and barrier layer (18), but does not extend through the wall of gelatin capsule (12) although it may extend part of the way into the capsule wall.  The exit orifice (24) may be formed as an opening as shown; or, while not shown, exit orifice (24) could be formed of a solid or semi-solid material that will dissolve, leach out, or otherwise provide an opening extending from the environment of use to the wall of the gelatin capsule to permit release of the liquid, active agent formulation when the dosage form is in the environment of use.
Patent NZ-522408-A (NZ)
Title: Method for producing calcium nitrate granules at controlled humidity and temperature conditions using fluidised bed granulators
Inventor: RABIE DIRK RENIER HENDRIK
IPC: C01F/
Filed: 2001-05-02
Abstract: A process for producing calcium nitrate granules where a calcium nitrate melt is sprayed into a re-circulating bed of a first fluidised bed granulator (10), wherein the re-circulating bed is supplied with air that has been conditioned to a relative humidity of less than 30% at 40°C and heated to a temperature of between 60°C and 100°C. Calcium nitrate granules formed in the first fluidised bed granulator (10) are introduced to a primary cooler (38) in the form of a second fluidised bed where the granules are cooled to from 50°C to 60°C by conditioned air. The granules are sorted in a sorter (42) and then cooled in a secondary cooler (48) to a temperature of less than 40°C, before being bagged. The granules so produced are hard and dry and do not break down easily during handling.
Patent NZ-523913-A (NZ)
Title: Body armor to defeat high-velocity projectile with milled overlapping plates
Inventor: NEAL MURRAY L
IPC: F41H5/04
Filed: 1999-11-09
Abstract: Discs having radii are milled between circumference and arcs corresponding in magnitude to the disc radius, so as to overlap.
Patent NZ-526196-A (NZ)
Title: Pharmaceutical compositions for the oral delivery comprising povidone or crospovidone and an acitve ingredient preferably the peptide calcitonin
Inventor: AULT JOSEPH M
IPC: A61K47/32
Filed: 2001-12-05
Abstract: A solid pharmaceutical composition suitable for the oral delivery of a pharmacologically active agent comprises the peptide calcitonin, crospovidone or povidone, and 5-CNAC. The composition can be used in the manufacture of a medicament for the treatment of a bone related disease or calcium disorder such as osteoporosis.
Patent NZ-526272-A (NZ)
Title: Fibrillation of natural fibres
Inventor: RUSSELL STEPHEN J
IPC: D06L4/40
Filed: 2001-12-05
Abstract: A textile fabric of fibrillated keratinous fibres characterised by the presence of fibrils, micro-fibrils and proto-fibrils; and a method of treating natural fibres which comprises: a pre-treatment to remove surface lipid materials or scales; a treatment to remove or partially remove intercellular cement; and the application of mechanical agitation to complete fibrillation.
Patent NZ-526370-A (NZ)
Title: A process for the preparation of 1-(aminomethyl) cyclohexaneacetic acid
Inventor: FERRARI MASSIMO
IPC: C07C227/40
Filed: 2001-11-29
Abstract: A conversion process of gabapentin hydrochloride into gabapentin comprising: a) dissolution of gabapentin hydrochloride in a solvent in which the gabapentin hydrochloride and the gabapentin are completely soluble; and b) subsequent addition of an amine that allows the removal of the chloride ion from the solution containing gabapentin hydrochloride, by precipitation of the hydrochloride of the same amine, leaving the gabapentin in solution in free amino acid form.
Patent NZ-530868-A (NZ)
Title: Radiolabeling kit and binding assay
Inventor: CHINN PAUL
IPC: G01N33/60
Filed: 2000-02-29
Abstract: A method for radiolabelling a chelator-conjugated antibody comprises (i) mixing chelator-conjugated antibody with a solution containing a therapeutic radiolabel and (ii) incubating the mixture for a relatively short amount of time at an appropriate temperature to produce radiolabelled antibody having greater than 95% radio incorporation, sufficient specific activity and at least 70% immunoreactivity such that it may be administered directly to a human patient with out further purification of the radiolabelled antibody from unincorporated radiolabel; and optionally (iii) diluting the labelled antibody to an appropriate concentration in formulation buffer for administration to a human patient without further purification of the radiolabelled antibody from unincorporated radiolabel, with the proviso that when the antibody is an anti-CD20 antibody the labeled antibody is not diluted. Preferably the chelator is selected from MX-DTPA, phenyl-DTPA, benzyl-DTPA, CHX-DTPA and DOTA and the radiolabel is Y90 chloride. (62) Divided out of 513788
Patent NZ-531351-A (NZ)
Title: Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation
Inventor: LOWE DEREK B
IPC: A61P3/06
Filed: 2002-07-25
Abstract: Indane acetic acid derivatives of formula (I) which are useful in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases.